Get started

Stockstobuy

RIVN Rivian Automotive Options Ahead of EarningsIf you haven`t sold RIVN on the recalls: Or last time ahead of earnings: Then Analyzing the options chain and the chart patterns of UPWK Upwork prior to the earnings report this week, I would consider purchasing the 10usd strike price Calls with an expiration date of 2024-1-19, for a premium of approximately $1.92. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.
NASDAQ:RIVNLong
by TopgOptions
4
QSI Quantum-Si Earnings Release on Monday, Before the BellIf you haven`t bought the Double Bottom: Then you should know that QSI, Quantum-Si incorporated, also known as The Protein Sequencing Company is bringing single-molecule protein sequencing to every lab, everywhere, enabling new discoveries that will transform the world we live in. Importance of Protein Sequencing: - Understanding Cellular Processes: Proteins are involved in virtually every cellular process, and their sequencing is vital for understanding how these processes are regulated and how dysfunction leads to diseases. - Drug Development: Protein sequencing assists in drug discovery by identifying specific targets for pharmaceutical intervention. This knowledge enables the design of drugs that can interact with specific proteins, thereby treating diseases more effectively. - Bioengineering and Enzyme Production: Protein sequencing is critical in the field of bioengineering, allowing the design of proteins with tailored functions for various applications, including industrial enzyme production and bioremediation. I think protein sequencing should have the same importance as gene sequencing. Gene sequencing has revolutionized medical research, agriculture, and our comprehension of evolutionary history. On the other hand, protein sequencing has paved the way for targeted drug development, bioengineering, and the investigation of cellular processes. QSI has cash and cash equivalents of $322.1 million as of March 31,2023 to provide a runway to support operations and invest in the business into 2026, and NO debt! This Quarter started he sale of PlatinumTM instruments and kits with a gross margin of 48.8%. QSI has a Market Cap of $485Mil vs CRSP, my favorite gene editing company, with a Market Cap of 4.046Bil. So there is still a lot of upside in QSI Quantum-Si incorporated! Looking forward to read your opinion about it.
NASDAQ:QSILong
by TopgOptions
JOHN KEELLS HOLDINGS PLC (JKH.N0000) at Strong Support ZoneEntry Point: 132 to 136 Profit Target: 175 ( Short Term ), 215 ( Mid Term ), 400+ ( Long Term ) Stop-Loss: 127 Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:JKH.N0000Long
by rukshan2102
1
QSI Quantum-Si | Why is so Bullish? Price Target ! If you haven`t bought the Double Bottom here: Then I'll try an explanation why QSI Quantum-Si incorporated is so Bullish right now! QSI is a protein sequencing company, which could be revolutionary, similar to the gene sequencing stocks. Quantum-Si Incorporated is dedicated to developing a protein detection platform that enables Next Generation Protein Sequencing (NGPS). This comprehensive platform consists of the Carbon automated sample preparation instrument, the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip, the Quantum-Si Cloud data analysis software, and reagent kits designed for use with its instruments. QSI's competitor, RXRX, experienced a significant boost in its stock price after announcing a $50 million investment from NVIDIA (NASDAQ: NVDA) on July 12. The investment was part of a private investment in public equity (PIPE) arrangement. With this deal, NVIDIA gains access to Recursion Pharmaceuticals' (NASDAQ: RXRX) extensive biochemical and genetic data. NVIDIA plans to utilize this data to train machine-learning models in support of its new BioNeMo service, an artificial intelligence (AI) tool for drug discovery. Simultaneously, NVIDIA will also collaborate with Recursion to enhance their own models for drug discovery. Apart from Quantum-Si's Platinum product, which began selling this quarter, the company also offers cloud-based proteomics data analysis software, made possible by their single-molecule detection and NGPS instrument with Time-Domain Sequencing chip. Considering this, I believe it's only a matter of time until a major chip developer, such as NVDA, or a cloud services company with interest in the field, makes an investment similar to NVDA's investment in RXRX. This is my growth thesis, and regarding the Price Target, I find $10 to be reasonable for now, and there's also the possibility of a potential buyout. Looking forward to read your opinion about it!
NASDAQ:QSILong
by TopgOptions
4
PSP Projects looking to Push harder and forwardPSP Projects Limited is a multidisciplinary construction company offering a diversified range of construction and allied services across industrial, institutional, government, government residential and residential projects in India. The company mainly offers construction value chain and provides end to end support in construction activities. PSP Projects CMP is 777.60. Negative aspects of the company are declining annual net profits and promoter holding decreasing. Positive aspects of the company are no debt, improving cash from operations annual, FIIs are increasing stake, MFs are increasing stake. Entry can be taken after closing above 780. Targets in the stock will be 800 and 819. Long term target in the stock will be 847 and 871. Stop loss in the stock should be maintained at closing below 707.
NSE:PSPPROJECT
by Happy_Candles_Investment
Sudarshan Chemicals looking to rotate and shineSudarshan Chemicals Industries Ltd is a global supplier of high-end pigments with a diverse range of products ranging from organic, inorganic and effect pigments to performance colorants, pearlescent pigments and speciality chemicals. Products of the company mainly use in Art and craft, paper, agriculture and textile. Sudarshan Chemicals Industries Ltd CMP is 487.10. Negative aspects of the company are high valuation ( P.E. = 75.3), declining annual net profits, MFs are decreasing stake. Positive aspects of the company are low debt, improving cash from operations annuals, FIIs are increasing stake, zero promoter pledge. Entry can be taken after closing above 498. Targets in the stock will be 520 and 542. Long term target in the stock will be 579. Stop loss in the stock should be maintained at closing below 458.
NSE:SUDARSCHEMLong
by Happy_Candles_Investment
New LogoAs you all have probably seen, we have changed our logo and name! Shortly, we will go online with our website on which were are going to provide you with free daily market updates - more than one per day. But for the time being, let us look at the 3M chart where we can see an increasingly strong bullish impulse. It is important that the pressure is kept high until we confidently cross the resistance at $117.80. There, we should see a small setback, before the bulls take over again. It is important that the course remains above $92.38.
NYSE:MMMLong
by MarketIntel
Siemens trying to break the mid channel resistanceSiemens Ltd. is a technology company focused on industry, infrastructure, digital transformation, transport as well as transmission and generation of electrical power. Siemens has signed a 3 billion euro ($3.25 billion) contract to supply and service freight trains in India. Siemens CMP is 3694.90. Negative aspects of the company are high valuation (P.E. = 69.7), declining cash from operations annual, MFs are decreasing stake. Positive aspects of the company are improving annual net profits, no debt, FIIs are increasing stake and zero promoter pledge. Entry after closing above 3713. Target of the call will be 3779 and 3881. Long term targets in the stock will be 3953. Stop loss in the stock should be maintained at closing below 3315.
NSE:SIEMENSLong
by Happy_Candles_Investment
Eid Parry trying to parry out of tough timesE.I.D. Parry (India) Ltd. is engaged in the business of Sugar and Nutraceuticals. The company is amongst the leading sugar manufacturers in India, E.I.D. Parry’s 9 sugar plants are spread across South India. It is also a part of the INR 369 Billion Murugappa Group, one of India’s leading business conglomerate. E.I.D. Parry (India) CMP is 480.70. Negative aspects of the company are declining annual net profits, promoter decreasing stake, FIIs are decreasing stake and MFs are decreasing stake. Positive aspects of the company are no debt and improving cash from operations annual. Entry after closing above 488. Target of the call will be 507 and 546. Long term targets in the stock will be 584 and 629. Stop loss in the stock should be maintained at closing below 435.
NSE:EIDPARRYLong
by Happy_Candles_Investment
Why Bayer Stock is a Great Long-Term Investment OpportunityBayer AG is a German multinational pharmaceutical and life sciences company founded in 1863. The company is headquartered in Leverkusen, Germany, and employs over 100,000 people worldwide. Bayer's core business areas are human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, and biotechnology products. Bayer stock is a great long-term investment opportunity for several reasons. The first one is that its stock has created a strong weekly demand level located at around 49 euros per share. This should be enough reason to buy Bayer AG stock shares. Secondly, the company has a strong history of financial stability and profitability. In addition, Bayer has a diversified product portfolio with exposure to many different industries. Bayer is committed to innovation and has a strong R&D pipeline. Bayer AG is a publicly traded company with shares that trade on the Frankfurt Stock Exchange, and the company has a market capitalization of over €51 billion. The company's stock has not performed well in recent years, losing more than 70% of its value since up more than 50% since 2016. It's now a great opportunity to buy shares of Bayer AG stock. There is a lot of profit potential with room to reach €88 per share and higher.
XETR:BAYNLong
by AlfonsoMoreno
ATUL Ltd.can accommodate growth. Atul Ltd. is an integrated chemical company serving about 4000 customers belonging to 30 industries across the world. The company product portfolio utility includes area of aromatics, crop protection, polymers, pharma ingredients and many more. Atul CMP is 7014.15. Negative aspects of the company are high valuation (P.E. = 45.7), declining annual net profits, FIIs are decreasing stake and MFs are decreasing stake. Positive aspects of the company are no debt and improving cash from operations annual. Entry after closing above 7056. Target of the call will be 7373 and 7884. Long term targets in the stock will be 8402 and 8921. Stop loss in the stock should be maintained at closing below 5594.
NSE:ATULLong
by Happy_Candles_Investment
LIC of India trying to make a comeback after consolidation.Life Insurance Corporation of India is the largest multinational insurance corporation and an institutional investor with an asset under management of more than 45 trillion INR. The company offers insurance plans, pension plans, unit linked plans, withdrawn plans and health plans with many other group schemes. Life Insurance Corporation CMP is 635.75. Negative aspects of the company are declining cash from operations and MFs are decreasing stake. Positive aspects of the company are improving annual net profits, no debt and zero promoter pledge. Entry after closing above 643. Target of the call will be 653 and 666. Long term targets in the stock will be 681 and 704. Stop loss in the stock should be maintained at closing below 595.
NSE:LICILong
by Happy_Candles_Investment